Delivery Order SPE2DB20D3101-SPE2DB25FRKF0

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 10 mg tablets. The contract has a firm fixed price, with a ceiling value of $57,426.15, and runs through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,967.72 firm-fixed-price contract is for the delivery of 4,567,520,514 units of Cetirizine HCl 5 mg tablets to support military healthcare programs. The contract has a period of performance through March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $5,337.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,213,468 units of Cetirizine HCL 5 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a $17,377.06 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,910,880 units of Cetirizine HCL 5 mg tablets, and has a completion date of November 28, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,564,415,916 units of Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has a firm fixed price of $2,826.93 and a period of performance ending on April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,324,108 units of Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has a total ceiling value of $3,115.11 and is a firm fixed price delivery order contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,347.25, is for the procurement of Cetirizine HCL 10 mg tablets, a common antihistamine medication. The contract is a firm-fixed-price delivery order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cetirizine HCL 10 mg tablets, a medication used to treat allergies. The contract has a total ceiling value of $47,373.42 and a period of performance through April 30, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition....
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The contract has a ceiling value of $1,031.04 and is for the delivery of 4564151985 units of Cetirizine 10mg 500 count tablets. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRKF0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 5 mg tablets. The contract has a firm fixed price of $12,843.01 and a performance period ending on May 15, 2025. The award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader efforts to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide.

Generated 8/13/25, 11:10 AM